According to the industry analysis report titled ‘India Non-Invasive Prenatal Testing (NIPT) Market and Forecast 2022 – 2028’, available with MarketStudyReport, India non-invasive prenatal testing market is anticipated to record a CAGR of 11% through 2028 and touch USD 62 million mark by the end of the forecast timeline.

Rising prevalence of genetic abnormalities, growing awareness regarding non-invasive prenatal testing methods, rapid adoption of IVF birthing procedure, and burgeoning popularity of DISC (Double Income, Single Child) families are the major factors driving India non-invasive prenatal testing market growth.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4559462/

Notably, India is known to be country with a very high birthrate and an equally high infant mortality rate which further necessitates early screening tests that may significantly reduce the risk endangering the life of both the mother and fetus.

Besides, the quick, safe, and highly reliable nature of non-invasive tests is bound to unearth new opportunities for revenue generation in the ensuing years.

Apart from growth drivers and challenges, the research literature also provides insights about the challenges and drawbacks prevailing in India non-invasive prenatal testing (NIPT) market. Information about the NIPTs conducted in India in the past years and forecast about the next six years is given. It also sheds light on the latest developments in field, while educating about the reimbursement scenario.

The competitive framework covering Thyrocare Technologies Ltd., Igenomix India Pvt. Ltd., Medgenome Inc., LifeCell Corporation, DNA Labs India, Fortis Healthcare Ltd., DNA Forensics Laboratory Pvt. Ltd., and Apollo Center for Fetal Medicine is entailed in the report. These companies are thoroughly analyzed in terms of their current portfolio, status of business operations, recent developments, and new product launches for readers to reach their own conclusions regarding the profitability of the organization.

Lastly, insights related to mergers & acquisitions, collaboration deals, distribution channels, licensing agreements, partnership deals, and similar developments are contained in India non-invasive prenatal testing industry report.